The federal agency said it was taking swift action to get more tests for screening asymptomatic people on the market.

T2 Biosystems CEO shares his personal heart transplant and sepsis survival story in a newly released book.

Part two of a three-part series explores the five pillars of the future of diagnostics.

The ability to diagnose at a point-of-care setting will help with more quickly and appropriately treating sexually-transmitted infections, expert says.

FDA has provided information on specific molecular tests impacted by viral mutations, and recommendations for those tests.

Hilden, Germany-based Qiagen inherited the test when it acquired the remaining stake in NeuMoDx Molecular for $248 million in 2020. The NeuMoDx assay's Emergency Use Authorization comes at a time when developments in COVID-19-related tests are...

Pressed for time? Here's the medtech news you need most, in one minute or less.

Part one of a three-part series on diagnostics explores how the COVID-19 pandemic is changing healthcare customers.

Everlywell and Vault Health enlist DoorDash to help deliver COVID-19 PCR test collection kits.

A deep-dive into how the pandemic turned an evolution into a revolution — and what to expect the future of diagnostic testing to look like.